Assignment of Assignor's Interest

Recorded: 2012-03-02 Received: 2012-03-02 Pages: 5

Assignor

AKEBIA THERAPEUTICS, INC.

Executed: 2012-02-29

Assignee

AERPIO THERAPEUTICS, INC.

9987 CARVER ROAD, SUITE 420, CINCINNATI, OH, 45242, UNITED STATES

Covered Properties (4)

HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS

Application: 12/610,843 →

Pharmaceutical Compositions That Modulate Hptpbeta Activity

Application: 11/787,535 →

Hptpbeta as a Target in Treatment of Angiogenesis Mediated Disorders

Application: 10/633,742 →

HPTPbeta as a target in treatment of angiogenesis mediated disorders

Application: 60/413,547 →